Table 4.
Treatment | PPARγ (%) | C/EBPα (%) |
---|---|---|
PG 1 mg/mL | 21.52 ± 5.28* | 43.42 ± 6.80** |
VN 1 mg/mL | 26.29 ± 3.47* | 40.65 ± 2.08** |
PG-VN combination 1 mg/mL | 28.87 ± 2.25* | 39.61 ± 3.82* |
PG-VN combination 2 mg/mL | 45.22 ± 3.88∗∗ab | 59.94 ± 1.94∗∗b |
xPG + VN | 47.81 ± 8.75 | 84.07 ± 8.88 |
x(PG + VN)/2 | 23.905 ± 4.375 | 42.035 ± 4.44 |
Values were expressed as means ± SD. *P < 0.05, significantly different from the Control; **P < 0.005, significantly different from the control; a P < 0.05, significantly different from PG; b P < 0.05, significantly different from VN. xCalculated additive response (the sum of the effects of the individual PG and VN treatments). Control, expression of the differentiated 3T3-L1 cells was considered as 0%; PG: Panax ginseng; VN: Veratrum nigrum.